Baicalein

百可利

Report date: 2026/05/28 20:00:21
NME

Base Information

Drug NameBaicalein
Drug Alias NameDL-0705
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionLipoxygenase inhibitors
TargetsLipoxygenase
Therapy Area/IndicationsParkinson DiseaseInfluenza, Human
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesJiangsu Kanion Pharmaceutical Co LtdInstitue Of Materia Medica Chinese Academy Of Medical Science
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesInstitue Of Materia Medica Chinese Academy Of Medical Science
Inactive CompaniesCspc Zhongqi Pharmaceutical Technology (Tianjin) Co Ltd
Active IndicationsParkinson Disease
Inactive IndicationsInfluenza, Human

Other Information

ATC CodeN/A
Related LinksN/A